A cross sectional study of bone and cartilage biomarkers: correlation with structural damage in rheumatoid arthritis

References

• Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum. 1997;27(2):1–7.
   Web of Science ®Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361.
   PubMed Web of Science ®Google Scholar
• Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet Lond Engl. 2010;376(9746):1094–1108.
   PubMed Web of Science ®Google Scholar
• van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol. 1995;34(Suppl 2):74–80.
   PubMedGoogle Scholar
• Scott DL, Pugner K, Kaarela K, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatol Oxf Engl. 2000;39(2):122–132.
   PubMed Web of Science ®Google Scholar
• Tan YK, Conaghan PG. Imaging in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2011;25(4):569–584.
   Web of Science ®Google Scholar
• Østergaard M, Pedersen SJ, Døhn UM. Imaging in rheumatoid arthritis–status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography. Best Pract Res Clin Rheumatol. 2008;22(6):1019–1044.
   Web of Science ®Google Scholar
• Salaffi F, Carotti M, Ciapetti A, et al. Validity of a computer-assisted manual segmentation software to quantify wrist erosion volume using computed tomography scans in rheumatoid arthritis. BMC Musculoskelet Disord. 2013;14:265.
   PubMed Web of Science ®Google Scholar
• Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011;63(3):573–586.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Woodworth T, Henriksen K, et al. Biochemical markers of ongoing joint damage in rheumatoid arthritis–current and future applications, limitations and opportunities. Arthritis Res Ther. 2011;13(2):215.
   Web of Science ®Google Scholar
• Seibel MJ. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int J. 2000;11(Suppl 6):S18–29.
   PubMedGoogle Scholar
• Christgau S, Garnero P, Fledelius C, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone. 2001;29(3):209–215.
   PubMed Web of Science ®Google Scholar
• Andersson MLE, Svensson B, Petersson IF, et al. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2013;14:229.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–1588.
   PubMed Web of Science ®Google Scholar
• Ostergaard M, Edmonds J, McQueen F, et al. An introduction to the EULAR–OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis. 2005;64(Suppl 1):i3–7.
   PubMed Web of Science ®Google Scholar
• Døhn UM, Ejbjerg BJ, Court-Payen M, et al. Are bone erosions detected by magnetic resonance imaging and ultrasonography true erosions? A comparison with computed tomography in rheumatoid arthritis metacarpophalangeal joints. Arthritis Res Ther. 2006;8(4):R110.
   PubMed Web of Science ®Google Scholar
• Perry D, Stewart N, Benton N, et al. Detection of erosions in the rheumatoid hand; a comparative study of multidetector computerized tomography versus magnetic resonance scanning. J Rheumatol. 2005;32(2):256–267.
   PubMed Web of Science ®Google Scholar
• Zhu L, Ouyang X, Zheng D, et al. Correlation between synovial TRAF6 expression and serum bone metabolism markers in rheumatoid arthritis. Zhonghua Yi Xue Za Zhi. 2014;94(21):1643–1646.
   Google Scholar
• Garnero P, Jouvenne P, Buchs N, et al. Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products. Bone. 1999;24(4):381–385.
   Web of Science ®Google Scholar
• Aschenberg S, Finzel S, Schmidt S, et al. Catabolic and anabolic periarticular bone changes in patients with rheumatoid arthritis: a computed tomography study on the role of age, disease duration and bone markers. Arthritis Res Ther. 2013;15(3):R62.
   PubMed Web of Science ®Google Scholar
• Jansen LMA, van der Horst-Bruinsma I, Lems WF, et al. Serological bone markers and joint damage in early polyarthritis. J Rheumatol. 2004;31(8):1491–1496.
   Web of Science ®Google Scholar
• Loët XL, Brazier M, Mejjad O, et al. Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: A simple model of prediction from a conservatively treated community-based inception cohort. Arthritis Care Res. 2010;62(12):1739–1747.
   Web of Science ®Google Scholar
• Krabben A, Knevel R, Huizinga TWJ, et al. Serum pyridinoline levels and prediction of severity of joint destruction in rheumatoid arthritis. J Rheumatol. 2013;40(8):1303–1306.
   Web of Science ®Google Scholar
• Gao HY, Li XF, Zhang BN, et al. The correlations of single photon emission computed tomography joints scan and bone metabolic markers in active rheumatoid arthritis. Zhonghua Nei Ke Za Zhi. 2016;55(11):845–848.
   Google Scholar
• Garnero P, Landewé R, Boers M, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum. 2002;46(11):2847–2856.
   PubMed Web of Science ®Google Scholar
• Garnero P, Gineyts E, Christgau S, et al. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum. 2002;46(1):21–30.
   PubMedGoogle Scholar
• Christensen AF, Lottenburger T, Lindegaard H, et al. Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis. Clin Exp Rheumatol. 2009;27(2):307–314.
   Web of Science ®Google Scholar
• Sassi M-L, Aman S, Hakala M, et al. Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike crosslaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis. Clin Chem Lab Med. 2003;41(8):1038–1044.
   Web of Science ®Google Scholar